Monetizing Science: Turning an Asset into Value through IPOs
PharmaTalkRadio16 Okt 2019

Monetizing Science: Turning an Asset into Value through IPOs

This panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. Panelists include: David Epstein, Flagship PioneeringDan Passeri, Cue Biopharma Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
jss
sinnsyn
liberal-halvtime
forskningno
tomprat-med-gunnar-tjomlid
fjellsportpodden
rss-overskuddsliv
villmarksliv
dekodet-2
rss-paradigmepodden
rss-inn-til-kjernen-med-sunniva-rose
rss-zahid-ali-hjelper-deg
kvinnehelsepodden
rss-rekommandert
hva-er-greia-med
nevropodden
aldring-og-helse-podden